Prosecution Insights
Last updated: May 29, 2026

The Children's Hospital of Philadelphia

22 pending office actions • 16 art units • 22 examiners • 0 of 22 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Portfolio Summary

22
Total Pending OAs
13
Non-Final OAs
6
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
1
Due this week
5
Due this month
2
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 7 days (1)Due ≤ 30 days (5)Due ≤ 60 days (2)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
19
Medium (86%)
1
Easy (5%)
2
Unknown (9%)

Rejection Statute Mix

BucketCases
§103 only19 (86%)
§112 only1 (5%)
No statute on record2 (9%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
68% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
7
Mechanical / Eng
32% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GEIGER, RACHAEL L 1 85.7% +13.6%
SWARTWOUT, BRIANNA KENDALL 1 46.0% +62.0%
PAULUS, ERIN VIRGINIA 1 37.5% +83.3%
JOHNSON, KARA D 1 69.1% +24.2%
MARTIN, PAUL C 1 42.0% +21.7%
ROWLAND, STEVE 1 77.6% +17.8%
ANDERSON, JAMES D 1 55.1% +19.2%
MCCLELLAN, JAMES S 1 79.1% +12.9%
HULL, JAMES B 1 44.8% +52.7%
LI, BAO Q 1 75.9% +26.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18703100 SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS GEIGER, RACHAEL L 54d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18341584 COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH AN IMPRINTING DEFECT ANDERSON, JAMES D 171d overdue
18424292 COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA PAULUS, ERIN VIRGINIA 45d overdue
18320927 SURGICAL REPAIR SIMULATION DEVICES HULL, JAMES B 28d overdue
18607961 METHODS AND COMPOSITIONS RELATING TO HIGH-THROUGHPUT MODELS FOR ANTIBODY DISCOVERY AND/OR OPTIMIZATION SWARTWOUT, BRIANNA KENDALL 11d overdue
18320921 SURGICAL REPAIR SIMULATION DEVICES MCCLELLAN, JAMES S 21d
18352808 SURGICAL REPAIR SIMULATION DEVICE ROWLAND, STEVE 27d
18508057 CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME JOHNSON, KARA D 30d
18313158 ADENO-ASSOCIATED VIRUS VECTORS LI, BAO Q 40d

Top Art Units

Art UnitApps
3715 3
1638 3
3771 2
1631 2
1644 1
1632 1
1653 1
1629 1
1671 1
1674 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18703100 SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS GEIGER, RACHAEL L 3771 §103 Non-Final OA 54d Pending Apr 19, 2024
18607961 METHODS AND COMPOSITIONS RELATING TO HIGH-THROUGHPUT MODELS FOR ANTIBODY DISCOVERY AND/OR OPTIMIZATION SWARTWOUT, BRIANNA KENDALL 1644 §103 Non-Final OA 11d overdue Pending Mar 18, 2024
18424292 COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA PAULUS, ERIN VIRGINIA 1631 §103 Non-Final OA 45d overdue Pending Jan 26, 2024
18508057 CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME JOHNSON, KARA D 1632 §103 Non-Final OA 30d Pending Nov 13, 2023
18286405 CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME MARTIN, PAUL C 1653 §103 Non-Final OA 61d Pending Oct 11, 2023
18352808 SURGICAL REPAIR SIMULATION DEVICE ROWLAND, STEVE 3715 §103 Final Rejection 27d Pending Jul 14, 2023
18341584 COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH AN IMPRINTING DEFECT ANDERSON, JAMES D 1629 Non-Final OA 171d overdue Pending Jun 26, 2023
18320921 SURGICAL REPAIR SIMULATION DEVICES MCCLELLAN, JAMES S 3715 §103 Final Rejection 21d Pending May 19, 2023
18320927 SURGICAL REPAIR SIMULATION DEVICES HULL, JAMES B 3715 §103 Non-Final OA 28d overdue Pending May 19, 2023
18313158 ADENO-ASSOCIATED VIRUS VECTORS LI, BAO Q 1671 §103 Non-Final OA 40d Pending May 05, 2023
18030733 NOTCH4 ANTIBODIES AND USES THEREOF HOWARD, ZACHARY C 1674 §112 Non-Final OA 114d overdue Pending Apr 06, 2023
18009645 USE OF HEAT SHOCK PROTEIN INHIBITORS FOR THE TREATMENT OF NEURODEVELOPMENTAL DISORDERS HUTTER, GILLIAN A 1625 §103 Non-Final OA 1d overdue Pending Dec 09, 2022
18009192 COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION MCCORMICK, CATHERINE LYNN 1638 §103 Non-Final OA 17d overdue Pending Dec 08, 2022
17915911 COMPUTER-BASED SYSTEMS AND DEVICES CONFIGURED FOR DEEP LEARNING FROM SENSOR DATA NON-INVASIVE SEIZURE FORECASTING AND METHODS THEREOF MALAMUD, DEBORAH LESLIE 3792 §103 Non-Final OA 4d overdue Pending Sep 29, 2022
17794895 ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE AMICK, THOMAS RUSSE 1638 §103 Non-Final OA 17d overdue Pending Jul 22, 2022
17738200 Bioelectronic Devices to Support Transplanted Cells in Vivo for Encapsulated Cell Therapies SHAH, NILAY J 3783 §103 Final Rejection 10d overdue Pending May 06, 2022
17767340 METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIA MCLEOD, AFRICA MHAIRIE 1635 Other Final Rejection 89d overdue Pending Apr 07, 2022
17764413 BCL11A GUIDE AND BASE EDITOR DELIVERY HUMPHRIES, NICHOLAS ADAM 1631 §103 Non-Final OA 89d overdue Pending Mar 28, 2022
17612465 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DBA USING GATA1 GENE THERAPY HILL, KEVIN KAI 1638 §103 Final Rejection 70d Pending Nov 18, 2021
17425272 COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS WHITEMAN, BRIAN A 1636 §103 Non-Final OA 29d Pending Jul 22, 2021
17058046 METHODS FOR TREATING SPINAL CORD INJURY CHONG, YONG SOO 1623 §103 Final Rejection 22d Pending Nov 23, 2020
16560358 METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR KNAUSS, CHRISTIAN D 3771 §103 Non-Final OA 5d Pending Sep 04, 2019

Managing The Children's Hospital of Philadelphia's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month